AI could help spot baby hip issues earlier
NCT ID NCT07488260
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether an artificial intelligence (AI) software can accurately analyze hip ultrasound images from infants screened for developmental dysplasia of the hip (DDH). About 150 babies will have their routine hip ultrasound read by both a doctor and the AI, and researchers will compare the results. If the AI matches the doctor's diagnosis often enough, it could become a helpful tool for faster or more consistent screening.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AI-supported hip ultrasound analysis software (Prelux)
What this could lead to
If successful, this AI tool could help doctors more quickly and consistently diagnose hip dysplasia in infants, potentially catching cases earlier.
What could go wrong
This is an early-stage study with only 150 infants, and the AI may not match the accuracy of trained physicians. It is designed to assist, not replace, doctors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEVELOPMENTAL DYSPLASIA OF THE HIP (DDH) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••